The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment

(2018) David Beran et al.   Current Diabetes Reports

Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases

(2017) Margaret Ewen et al.   PLoS One

Constraints and challenges in access to insulin: a global perspective

(2016) David Beran et al.   Lancet Diabetes & Endocrinology

A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China

(2015) Xiaoyu Xi et al.   BMC HEALTH SERVICES RESEARCH

Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review

(2015) Sarah Colgan et al.   BMJ Open

A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?

(2015) Else-Lydia Toverud et al.   Applied Health Economics and Health Policy

A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka

(2014) Panthihage Ruvini L Dabare et al.   BMC PUBLIC HEALTH

The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania

(2014) Amani Thomas Mori et al.   PLoS One

The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries

(2013) Zaheer-Ud-Din Babar et al.   PHARMACOECONOMICS

The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use

(2013) Mohamed Azmi Hassali et al.   SAUDI PHARMACEUTICAL JOURNAL

Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review

(2012) Amani Thomas Mori et al.   BMC Medical Informatics and Decision Making

The ‘Wise List’- A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

(2011) Lars L. Gustafsson et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data

(2010) Maaike SM van Mourik et al.   BMC Cardiovascular Disorders

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report—Part VI

(2009) Lizheng Shi et al.   VALUE IN HEALTH

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

(2008) A Cameron et al.   LANCET